← FTC press releases
FTC Approves Final Order Requiring Bristol-Myers Squibb Company and Celgene Corporation to Divest Psoriasis Drug Otezla as a Condition of Acquisition
other · 2020-01-01
Source
- Authoritative
- FTC press release
- Machine
- JSON-LD · Markdown